Literature DB >> 21843968

Efficiency of aseptic open vitrification and hermetical cryostorage of human oocytes.

L Parmegiani1, G E Cognigni, S Bernardi, S Cuomo, W Ciampaglia, F E Infante, C Tabarelli de Fatis, A Arnone, A M Maccarini, M Filicori.   

Abstract

The present study reports, as far as is known for the first time, the safety of UV sterilization of liquid nitrogen and hermetical cryostorage of human oocytes by comparing the efficiency of fresh and vitrified sibling oocytes of infertile patients. A prospective randomized study on sibling oocytes of 31 patients was carried out. Metaphase-II oocytes were randomized for intracytoplasmic sperm injection and the supernumerary sibling oocytes were vitrified using a novel Cryotop aseptic procedure (UV liquid nitrogen sterilization and hermetical cryostorage). After unsuccessful attempts with fresh oocytes, vitrified sibling oocytes were injected. Mean outcome measures observed were fertilization, cleavage and top-quality embryo rates. No significant differences were observed between the fresh and vitrified-warmed sibling oocytes: oocyte fertilization was 88.3% versus 84.9%; cleavage 72.6% versus 71.0%; top-quality embryos 33.8% versus 26.3% and mean number of transferred embryos 2.6 ± 0.1 versus 2.5 ± 0.1, respectively. Clinical pregnancy rate per cycle with vitrified-warmed oocytes was 35.5% (implantation rate 17.1%) and seven healthy babies were born. This study demonstrated that UV liquid nitrogen sterilization and hermetical cryostorage does not adversely affect the developmental competence of vitrified oocytes, allowing safe aseptic open vitrification applicable under strict directives on tissue manipulation.
Copyright © 2011 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21843968     DOI: 10.1016/j.rbmo.2011.07.003

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  32 in total

1.  Vitrification of in vitro matured oocytes diminishes embryo development potential before but not after embryo genomic activation.

Authors:  Yijuan Sun; Ruihuan Gu; Xiaowei Lu; Shen Zhao; Yun Feng
Journal:  J Assist Reprod Genet       Date:  2015-12-21       Impact factor: 3.412

2.  Is employer coverage of elective egg freezing coercive?: a survey of medical students' knowledge, intentions, and attitudes towards elective egg freezing and employer coverage.

Authors:  Deborah E Ikhena-Abel; Rafael Confino; Nirali J Shah; Angela K Lawson; Susan C Klock; Jared C Robins; Mary Ellen Pavone
Journal:  J Assist Reprod Genet       Date:  2017-06-02       Impact factor: 3.412

3.  Is Fertility Preservation Feasible and Safe With Neoadjuvant Therapy for Breast Cancer?

Authors:  Avner Hershlag; Christine Mullin; Sara L Bristow
Journal:  J Glob Oncol       Date:  2018-09

4.  Survival and post-warming in vitro competence of human oocytes after high security closed system vitrification.

Authors:  N De Munck; G Verheyen; L Van Landuyt; D Stoop; H Van de Velde
Journal:  J Assist Reprod Genet       Date:  2013-01-25       Impact factor: 3.412

5.  Live birth in a 46 year old using autologous oocytes cryopreserved for a duration of 3 years: a case report documenting fertility preservation at an advanced reproductive age.

Authors:  Susan M Maxwell; Kara N Goldman; Patty A Labella; Caroline McCaffrey; Nicole L Noyes; James Grifo
Journal:  J Assist Reprod Genet       Date:  2014-03-08       Impact factor: 3.412

6.  Oocyte vitrification: advances, progress and future goals.

Authors:  Ri-Cheng Chian; Yao Wang; Yi-Ran Li
Journal:  J Assist Reprod Genet       Date:  2014-01-30       Impact factor: 3.412

7.  For whom the egg thaws: insights from an analysis of 10 years of frozen egg thaw data from two UK clinics, 2008-2017.

Authors:  Zeynep B Gürtin; Lucy Morgan; David O'Rourke; Jinjun Wang; Kamal Ahuja
Journal:  J Assist Reprod Genet       Date:  2019-05-23       Impact factor: 3.412

8.  "Universal Warming" protocol for vitrified oocytes to streamline cell exchange for transnational donation programs: a multi-center study.

Authors:  Lodovico Parmegiani; M G Minasi; A Arnone; V Casciani; G E Cognigni; R Viñoles; M T Varricchio; L A Quintero; E Greco; M Filicori
Journal:  J Assist Reprod Genet       Date:  2020-05-03       Impact factor: 3.412

9.  Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013.

Authors:  Sara Crawford; Sheree L Boulet; Jennifer F Kawwass; Denise J Jamieson; Dmitry M Kissin
Journal:  Fertil Steril       Date:  2016-11-11       Impact factor: 7.329

Review 10.  Preserving human cells for regenerative, reproductive, and transfusion medicine.

Authors:  Waseem Asghar; Rami El Assal; Hadi Shafiee; Raymond M Anchan; Utkan Demirci
Journal:  Biotechnol J       Date:  2014-07       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.